Ofer Shpilberg

Research interests

Publications

• Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

  Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01232-w

• Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)33008-9

• Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx223

• Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.213

• ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

  Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds517

• Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.41.9416

• CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70235-2

• Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045

• Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.28.1618

• Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials

  JNCI Journal of the National Cancer Institute · 2009 · https://doi.org/10.1093/jnci/djn478

• Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

  The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(08)70078-0

• Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0801479

• CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

  The Lancet Oncology · 2006 · https://doi.org/10.1016/s1470-2045(06)70664-7

• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  Journal of Clinical Oncology · 1997 · https://doi.org/10.1200/jco.1997.15.2.433

Current projects

No projects listed.